|
| Targeting primary mediastinal Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.2351
Simon D. Wagner
|
| 6552-6553 |
|
| Spy1/SpeedyA accelerates neuroblastoma |
|
https://doi.org/10.18632/oncotarget.2380
Xavier Bisteau, and Philipp Kaldis
|
| 6554-6555 |
|
| Chemoprevention of metastasis |
|
https://doi.org/10.18632/oncotarget.2382
Nancy J. Emenaker, Enrique Zudaire, and Brad St. Croix
|
| 6556-6557 |
|
| HDAC inhibitors and immunotherapy; a double edged sword |
|
https://doi.org/10.18632/oncotarget.2289
Michiel Kroesen, Paul R. Gielen, Ingrid C. Brok, Inna Armandari, Peter M. Hoogerbrugge, and Gosse J. Adema
|
| 6558-6572 |
|
| Enteric pathogens and cellular transformation: bridging the gaps |
|
https://doi.org/10.18632/oncotarget.2384
Shahid Umar
|
| 6573-6575 |
|
| Upregulation of chemokine receptor CCR10 is essential for glioma proliferation invasion and patient survival |
|
https://doi.org/10.18632/oncotarget.2134
Lingchao Chen, Xing Liu, Hai-Yan Zhang, Wenzong Du, Zhiyong Qin, Yu Yao, Ying Mao, and Liangfu Zhou
|
| 6576-6583 |
|
| Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma |
|
https://doi.org/10.18632/oncotarget.2172
Ishwaria M. Subbiah, Shanda H. Blackmon, Arlene M. Correa, Bryan Kee, Ara A. Vaporciyan, Stephen G. Swisher, and Cathy Eng
|
| 6584-6593 |
|
| Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer |
|
https://doi.org/10.18632/oncotarget.2175
Yilin Li, Xiaotian Zhang, Sai Ge, Jing Gao, Jifang Gong, Ming Lu, Qiyue Zhang, Yanshuo Cao, Daisy Dandan Wang, Peter Ping Lin, and Lin Shen
|
| 6594-6602 |
|
| Genomewide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development |
|
https://doi.org/10.18632/oncotarget.2224
Xiu-Xia Wang, Jing-Zan Wei, Jiao Jiao, Shu-Yi Jiang, Da-Hai Yu, and Da Li
|
| 6603-6610 |
|
| Circulating miR182 is a biomarker of colorectal adenocarcinoma progression |
|
https://doi.org/10.18632/oncotarget.2245
Lisa Perilli, Caterina Vicentini, Marco Agostini, Silvia Pizzini, Marco Pizzi, Edoardo D’ D. Angelo, Stefania Bortoluzzi, Susanna Mandruzzato, Enzo Mammano, Massimo Rugge, Donato Nitti, Aldo Scarpa, Matteo Fassan, and Paola Zanovello
|
| 6611-6619 |
|
| Epidermal growth factor receptor EGFR is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatinbased neoadjuvant chemotherapy |
|
https://doi.org/10.18632/oncotarget.2268
Michaela Aichler, Martin Motschmann, Uta Jütting, Birgit Luber, Karen Becker, Katja Ott, Florian Lordick, Rupert Langer, Marcus Feith, Jörg Rüdiger Siewert, and Axel Walch
|
| 6620-6632 |
|
| ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer |
|
https://doi.org/10.18632/oncotarget.1955
Katharina Feldinger, Daniele Generali, Gabriela Kramer-Marek, Merel Gijsen, Tzi Bun Ng, Jack Ho Wong, Carla Strina, Mariarosa Cappelletti, Daniele Andreis, Ji-Liang Li, Esther Bridges, Helen Turley, Russell Leek, Ioannis Roxanis, Jacek Capala, Gillian Murphy, Adrian L. Harris, and Anthony Kong
|
| 6633-6646 |
|
| Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL |
|
https://doi.org/10.18632/oncotarget.2160
Aneta Schieferdecker, Mareike Voigt, Kristoffer Riecken, Friederike Braig, Thorsten Schinke, Sonja Loges, Carsten Bokemeyer, Boris Fehse, and Mascha Binder
|
| 6647-6653 |
|
| The miR124Prolyl Hydroxylase P4HA1MMP1 axis plays a critical role in prostate cancer progression |
|
https://doi.org/10.18632/oncotarget.2208
Balabhadrapatruni V. S. K. Chakravarthi, Satya S. Pathi, Moloy T. Goswami, Marcin Cieślik, Heng Zheng, Sivakumar Nallasivam, Subramanyeswara R. Arekapudi, Xiaojun Jing, Javed Siddiqui, Jyoti Athanikar, Shannon L. Carskadon, Robert J. Lonigro, Lakshmi P. Kunju, Arul M. Chinnaiyan, Nallasivam Palanisamy, and Sooryanarayana Varambally
|
| 6654-6669 |
|
| Fructose26Bisphosphate synthesis by 6Phosphofructo2Kinase/Fructose26Bisphosphatase 4 PFKFB4 is required for the glycolytic response to hypoxia and tumor growth |
|
https://doi.org/10.18632/oncotarget.2213
Jason Chesney, Jennifer Clark, Alden C. Klarer, Yoannis Imbert-Fernandez, Andrew N. Lane, and Sucheta Telang
|
| 6670-6686 |
|
| Systemic miRNA7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma |
|
https://doi.org/10.18632/oncotarget.2235
Negar Babae, Meriem Bourajjaj, Yijia Liu, Judy R. Van Beijnum, Francesco Cerisoli, Puthupparampil V. Scaria, Mark Verheul, Maaike P. Van Berkel, Ebel H. E. Pieters, Rick J. Van Haastert, Afrouz Yousefi, Enrico Mastrobattista, Gert Storm, Eugene Berezikov, Edwin Cuppen, Martin Woodle, Roel Q. J. Schaapveld, Gregoire P. Prevost, Arjan W. Griffioen, Paula I. Van Noort, and Raymond M. Schiffelers
|
| 6687-6700 |
|
| DNA methylationmediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrinRho GTPase signaling |
|
https://doi.org/10.18632/oncotarget.2239
Ying Fu, Ming-Xuan Feng, Jian Yu, Ming-Ze Ma Ma, Xiao-Jin Liu, Jun Li, Xiao-Mei Yang, Ya-Hui Wang, Yan-Li Zhang, Jun-Ping Ao, Feng Xue, Wenxin Qin, Jianren Gu, Qiang Xia, and Zhi-Gang Zhang
|
| 6701-6715 |
|
| Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression |
|
https://doi.org/10.18632/oncotarget.2236
Feng-Wei Wang, Mu-Yan Cai, Shi-Juan Mai, Jie-Wei Chen, Hai-Yan Bai, Yan Li, Yi-Ji Liao, Chang-Peng Li, Xiao-Peng Tian, Hsiang-Fu Kung, Xin-Yuan Guan, and Dan Xie
|
| 6716-6733 |
|
| RASAL2 downregulation in ovarian cancer promotes epithelialmesenchymal transition and metastasis |
|
https://doi.org/10.18632/oncotarget.2244
Yuting Huang, Meng Zhao, Haixu Xu, Ke Wang, Zheng Fu, Yuan Jiang, and Zhi Yao
|
| 6734-6745 |
|
| SAG/RBX2 is a novel substrate of NEDD41 E3 ubiquitin ligase and mediates NEDD41 induced chemosensitization |
|
https://doi.org/10.18632/oncotarget.2246
Weihua Zhou, Jie Xu, Yongchao Zhao, and Yi Sun
|
| 6746-6755 |
|
| CPEB1 modulates differentiation of glioma stem cells via downregulation of HES1 and SIRT1 expression |
|
https://doi.org/10.18632/oncotarget.2250
Jinlong Yin, Gunwoo Park, Jeong Eun Lee, Ju Young Park, Tae-Hoon Kim, Youn-Jae Kim, Seung-Hoon Lee, Heon Yoo, Jong Heon Kim, and Jong Bae Park
|
| 6756-6769 |
|
| The BCL92 protooncogene governs estrogen receptor alpha expression in breast tumorigenesis |
|
https://doi.org/10.18632/oncotarget.2252
Nathalie Zatula, Maria Wiese, Jens Bunzendahl, Walter Birchmeier, Christina Perske, Annalen Bleckmann, and Felix H. Brembeck
|
| 6770-6787 |
|
| Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.2253
Laia Rosich, Arnau Montraveta, SÃlvia Xargay-Torrent, Mónica López-Guerra, Jocabed Roldán, Marta Aymerich, Itziar Salaverria, SÃlvia Beà , ElÃas Campo, Patricia Pérez-Galán, Gaël Roué, and Dolors Colomer
|
| 6788-6800 |
|
| AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloidderived suppressor cells |
|
https://doi.org/10.18632/oncotarget.2254
Sarah K. Maenhout, Stephanie Du Four, Jurgen Corthals, Bart Neyns, Kris Thielemans, and Joeri L. Aerts
|
| 6801-6815 |
|
| Release of Ca2+ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrolinduced paraptosis in cancer cells |
|
https://doi.org/10.18632/oncotarget.2256
Mi Jin Yoon, A Reum Lee, Soo Ah Jeong, You-Sun Kim, Jin Yeop Kim, Yong-Jun Kwon, and Kyeong Sook Choi
|
| 6816-6831 |
|
| IGF2BP3mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.2257
Keisuke Taniuchi, Mutsuo Furihata, Kazuhiro Hanazaki, Motoaki Saito, and Toshiji Saibara
|
| 6832-6845 |
|
| The antiapoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma SCLC tumor growth |
|
https://doi.org/10.18632/oncotarget.2261
Gennaro Chiappetta, Anna Basile, Antonio Barbieri, Antonia Falco, Alessandra Rosati, Michelina Festa, Rosa Pasquinelli, Daniela Califano, Giuseppe Palma, Raffaele Costanzo, Daniela Barcaroli, Mario Capunzo, Renato Franco, Gaetano Rocco, Maria Pascale, Maria Caterina Turco, Vincenzo De Laurenzi, and Claudio Arra
|
| 6846-6853 |
|
| CD271 is a functional and targetable marker of tumorinitiating cells in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2269
Oihana Murillo-Sauca, Man Ki Chung, June Ho Shin, Christina Karamboulas, Shirley Kwok, Young Ho Jung, Richard Oakley, James R. Tysome, Lovisa O. Farnebo, Michael J. Kaplan, Davud Sirjani, Vasu Divi, F. Christopher Holsinger, Chafeek Tomeh, Anthony Nichols, Quynh T. Le, A. Dimitrios Colevas, Christina S. Kong, Ravindra Uppaluri, James S. Lewis Jr, Laurie E. Ailles, and John B. Sunwoo
|
| 6854-6866 |
|
| Protein kinase D1 attenuates tumorigenesis in colon cancer by modulating βcatenin/T cell factor activity |
|
https://doi.org/10.18632/oncotarget.2277
Vasudha Sundram, Aditya Ganju, Joshua E. Hughes, Sheema Khan, Subhash C. Chauhan, and Meena Jaggi
|
| 6867-6884 |
|
| NOTCH1 signaling contributes to cell growth antiapoptosis and metastasis in salivary adenoid cystic carcinoma |
|
https://doi.org/10.18632/oncotarget.2321
Bo-Hua Su, Jing Qu, Min Song, Xiao-Yu Huang, Xiao-Meng Hu, Jian Xie, Yong Zhao, Lin-Can Ding, Lin She, Jiang Chen, Li-Song Lin, Xu Lin, Da-Li Zheng, and You-Guang Lu
|
| 6885-6895 |
|
| The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis |
|
https://doi.org/10.18632/oncotarget.2229
Sze Ue Iris Luk, Hui Xue, Hongwei Cheng, Dong Lin, Peter W. Gout, Ladan Fazli, Colin C. Collins, Martin E. Gleave, and Yuzhuo Wang
|
| 6896-6908 |
|
| Transcriptional regulation of the p73 gene by Nrf2 and promoter CpG methylation in human breast cancer |
|
https://doi.org/10.18632/oncotarget.2230
Jing Lai, Weiwei Nie, Wenwen Zhang, Yucai Wang, Ruilian Xie, Yanru Wang, Jun Gu, Jing Xu, Wei Song, Fang Yang, Guichun Huang, Peng Cao, and Xiaoxiang Guan
|
| 6909-6922 |
|
| Epigenetic regulations in the IFNγ signalling pathway: IFNγmediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigenpresenting machinery genes |
|
https://doi.org/10.18632/oncotarget.2222
Veronika Vlková, Ivan Å tÄ›pánek, Veronika HruÅ¡ková, Filip Å enigl, Veronika Mayerová, Martin Å rámek, Jana Å Ãmová, Jana Bieblová, Marie Indrová, Tomáš Hejhal, Nicolas Dérian, David Klatzmann, Adrien Six, and Milan ReiniÅ¡
|
| 6923-6935 |
|
| Tuberindeficiency downregulates Ncadherin and upregulates vimentin in kidney tumor of TSC patients |
|
https://doi.org/10.18632/oncotarget.2206
Sitai Liang, Tiffanie Salas, Emre Gencaslan, Baojie Li, and Samy L. Habib
|
| 6936-6946 |
|
| A generic cycling hypoxiaderived prognostic gene signature: application to breast cancer profiling |
|
https://doi.org/10.18632/oncotarget.2285
Romain Boidot, Samuel Branders, Thibault Helleputte, Laila Illan Rubio, Pierre Dupont, and Olivier Feron
|
| 6947-6963 |
|
| USP17 is required for clathrin mediated endocytosis of epidermal growth factor receptor |
|
https://doi.org/10.18632/oncotarget.2165
Jakub Jaworski, Michelle de la Vega, Sarah J. Fletcher, Cheryl McFarlane, Michelle K. Greene, Andrew W. Smyth, Sandra Van Schaeybroeck, James A. Johnston, Christopher J. Scott, Joshua Z. Rappoport, and James F. Burrows
|
| 6964-6975 |
|
| Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis |
|
https://doi.org/10.18632/oncotarget.2106
Berenice Ortiz, Julie R. White, Wei H. Wu, and Timothy A. Chan
|
| 6976-6982 |
|
| MiR497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis |
|
https://doi.org/10.18632/oncotarget.2184
Jianwei Xu, Tianxiao Wang, Zhe Cao, Hua Huang, Jian Li, Wenjing Liu, Shanglong Liu, Lei You, Li Zhou, Taiping Zhang, and Yupei Zhao
|
| 6983-6993 |
|
| Development optimization and validation of novel antiTEM1/CD248 affinity agent for optical imaging in cancer |
|
https://doi.org/10.18632/oncotarget.2188
Chunsheng Li, Junying Wang, Jia Hu, Yi Feng, Kosei Hasegawa, Xiaohui Peng, Xingmei Duan, Aizhi Zhao, John L. Mikitsh, Vladimir R. Muzykantov, Ann-Marie Chacko, Daniel A. Pryma, Steven M. Dunn, and George Coukos
|
| 6994-7012 |
|
| MicroRNA25 regulates chemoresistanceassociated autophagy in breast cancer cells a process modulated by the natural autophagy inducer isoliquiritigenin |
|
https://doi.org/10.18632/oncotarget.2192
Zhiyu Wang, Neng Wang, Pengxi Liu, Qianjun Chen, Honglin Situ, Ting Xie, Jianxing Zhang, Cheng Peng, Yi Lin, and Jianping Chen
|
| 7013-7026 |
|
| The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics |
|
https://doi.org/10.18632/oncotarget.2053
Maximilian Boesch, Alain G. Zeimet, Daniel Reimer, Stefan Schmidt, Guenther Gastl, Walther Parson, Franziska Spoeck, Jiri Hatina, Dominik Wolf, and Sieghart Sopper
|
| 7027-7039 |
|
| KIAA1199 interacts with glycogen phosphorylase kinase βsubunit PHKB to promote glycogen breakdown and cancer cell survival |
|
https://doi.org/10.18632/oncotarget.2220
Masato Terashima, Yoshihiko Fujita, Yosuke Togashi, Kazuko Sakai, Marco A. De Velasco, Shuta Tomida, and Kazuto Nishio
|
| 7040-7050 |
|
| Critical role of STAT3 in melanoma metastasis through anoikis resistance |
|
https://doi.org/10.18632/oncotarget.2251
Neel M. Fofaria, and Sanjay K. Srivastava
|
| 7051-7064 |
|
| Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.2295
Adam D. Steg, Mata R. Burke, Hope M. Amm, Ashwini A. Katre, Zachary C. Dobbin, Dae Hoon Jeong, and Charles N. Landen
|
| 7065-7080 |
|
| Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway |
|
https://doi.org/10.18632/oncotarget.2162
Urszula L. McClurg, Emma E. Summerscales, Victoria J. Harle, Luke Gaughan, and Craig N. Robson
|
| 7081-7092 |
|
| DeSUMOylation of FOXC2 by SENP3 promotes the epithelialmesenchymal transition in gastric cancer cells |
|
https://doi.org/10.18632/oncotarget.2197
Yan-hua Ren, Ke-jia Liu, Ming Wang, Ya-nan Yu, Kai Yang, Qin Chen, Bin Yu, Wei Wang, Qi-wei Li, Jian Wang, Zhao-yuan Hou, Jing-yuan Fang, Edward T. Yeh, Jie Yang, and Jing Yi
|
| 7093-7104 |
|
| Phosphatidylserineselective targeting and anticancer effects of SapCDOPS nanovesicles on brain tumors |
|
https://doi.org/10.18632/oncotarget.2214
VÃctor M. Blanco, Zhengtao Chu, Subrahmanya D. Vallabhapurapu, Mahaboob K. Sulaiman, Ady Kendler, Olivier Rixe, Ronald E. Warnick, Robert S. Franco, and Xiaoyang Qi
|
| 7105-7118 |
|
| Tumortargeting Salmonella typhimurium A1R prevents experimental human breast cancer bone metastasis in nude mice |
|
https://doi.org/10.18632/oncotarget.2226
Shinji Miwa, Shuya Yano, Yong Zhang, Yasunori Matsumoto, Fuminari Uehara, Mako Yamamoto, Yukihiko Hiroshima, Hiroaki Kimura, Katsuhiro Hayashi, Norio Yamamoto, Michael Bouvet, Hiroyuki Tsuchiya, Robert M. Hoffman, and Ming Zhao
|
| 7119-7125 |
|
| Xlinked inhibitor of apoptosis protein XIAP lacking RING domain localizes to the nuclear and promotes cancer cell anchorageindependent growth by targeting the E2F1/Cyclin E axis |
|
https://doi.org/10.18632/oncotarget.2227
Zipeng Cao, Xueyong Li, Jingxia Li, Wenjing Luo, Chuanshu Huang, and Jingyuan Chen
|
| 7126-7137 |
|
| HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models |
|
https://doi.org/10.18632/oncotarget.2231
Gaëlle Thomas, Thierry Chardès, Nadège Gaborit, Caroline Mollevi, Wilhem Leconet, Bruno Robert, Nina Radosevic-Robin, Frédérique Penault-Llorca, Céline Gongora, Pierre-Emmanuel Colombo, Yassamine Lazrek, Rui Bras-Goncalves, Ariel Savina, David Azria, Hervé Bazin, André Pèlegrin, and Christel Larbouret
|
| 7138-7148 |
|
| In comparative analysis of multikinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy |
|
https://doi.org/10.18632/oncotarget.2240
Rogerio B. Craveiro, Michael Ehrhardt, Martin I. Holst, Thorsten Pietsch, and Dagmar Dilloo
|
| 7149-7161 |
|
| Transcribed ultraconserved noncoding RNAs TUCR are involved in Barrett’s esophagus carcinogenesis |
|
https://doi.org/10.18632/oncotarget.2249
Matteo Fassan, Luigi Dall’Olmo, Marco Galasso, Chiara Braconi, Marco Pizzi, Stefano Realdon, Stefano Volinia, Nicola Valeri, Pierluigi Gasparini, Raffaele Baffa, Rhonda F. Souza, Caterina Vicentini, Edoardo D’Angelo, Jan Bornschein, Gerard J. Nuovo, Giovanni Zaninotto, Carlo M. Croce, and Massimo Rugge
|
| 7162-7171 |
|
| EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2262
Swathi Chinaranagari, Pankaj Sharma, and Jaideep Chaudhary
|
| 7172-7182 |
|
| Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2293
Si Zhang, Wenqing Tang, Shuqiang Weng, Xijun Liu, Benqiang Rao, Jianxin Gu, She Chen, Qun Wang, Xizhong Shen, Ruyi Xue, and Ling Dong
|
| 7183-7197 |
|
| Mapping of apoptininteraction with BCRABL1 and development of apoptinbased targeted therapy |
|
https://doi.org/10.18632/oncotarget.2278
Jaganmohan R. Jangamreddy, Soumya Panigrahi, Kourosh Lotfi, Manisha Yadav, Subbareddy Maddika, Anil Kumar Tripathi, Sabyasachi Sanyal, and Marek J. Åos
|
| 7198-7211 |
